See also this year's filing and all EDGAR filings for this company.
PDF Report 0001868912_2022_Enfusion_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001868912')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001868912, Enfusion Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 8,106,000 |
| 1 | LongTermDebt | 538,000 |
| 2 | remainder_Liabilities | 0 |
| 3 | IntangibleAssets | 0 |
| 4 | AssetsNoncurrent | 3,356,000 |
| 5 | AssetsCurrent | 89,678,000 |
| 6 | PropertyPlantAndEquipmentNet | 13,051,000 |
| 7 | remainder_Assets | 0 |
| 8 | SellingAndMarketingExpense | 51,725,000 |
| 9 | GeneralAndAdministrativeExpense | 150,614,000 |
| 10 | ResearchAndDevelopmentExpense | 0 |
| 11 | remainder_Expenses | 185,824,000 |
| 12 | remainder_Revenues | 111,700,000 |
| 13 | remainder_NetIncome | -5,779,000 |
| 14 | remainder_ComprehensiveNetIncome | 123,812,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 8,644,000 |
| 1 | Assets | 106,085,000 |
| 2 | Expenses | 388,163,000 |
| 3 | Revenues | 111,700,000 |
| 4 | StockholdersEquity | 97,441,000 |
| 5 | NetIncome | -282,242,000 |
| 6 | ComprehensiveNetIncome | -158,430,000 |
| 7 | BaseVar | 372,091,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.84 |
| 9 | EconomicCapitalRatio | 4.44 |
Edgar->Model Mapping
Feature Distribution
